Placing Shares Admitted

RNS Number : 8758Y

Accrol Group Holdings PLC

11 December 2017

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

Accrol Group Holdings plc

(AIM: ACRL)

Placing Shares Admitted, Appointment of Director

And Total Voting Rights

Accrol Group Holdings plc (the "Company" or "Accrol"), the AIM-listed leading independent tissue converter, notes that the 36,000,000 new ordinary shares issued pursuant to the recently announced Placing to raise £18 million have been admitted to trading earlier today ("Admission"). As a consequence, the Revised Banking Facilities and the appointment of Dan Wright as a Director of the Company (each as described in the Company's announcement of 20 November 2017 titled "Proposed Placing of £18m and Lifting of Suspension") are now effective.

Peter Cheung, Chairman of Accrol, said: "I would like to take this opportunity to thank all our shareholders, once again, for their support and understanding over the past two months.

"On behalf of all the directors, I am delighted to welcome Dan to the Board. Dan is an experienced operator with considerable knowledge of our business and a strong understanding of the mechanics of the industry and we look forward to working with him."

Dan Wright

The following information on Dan Wright is required to be disclosed under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies:

Daniel ("Dan") Patrick Wright, aged 45, is currently a director of the following companies:

· NorthEdge Capital I GP LLP

· Waterloo Street BPRA Property Fund LLP

· Vision Support Services Group Limited

· Impulse Partners Limited

· Gomrath Limited

In addition, Dan has held the following directorships in the past five years:

· Highflex Holdings (UK) Limited (in administration effective 2 August 2017)

· NorthEdge Capital Fund I GP Limited

· NorthEdge Capital Corporate Limited

· NorthEdge Capital Nominee Limited

· NorthEdge Capital Founder GP Limited

· Accrol Group Holdings plc

· Accrol UK Limited

· MP Topco Limited

· Bretherton Barns Limited

· NorthEdge Capital LLP

· Piccadilly Assured Homes Limited

· P. & M.J. Wright (Holdings) Limited

Dan is interested in 200,000 Accrol Shares representing 0.16% of the entire issued share capital of Accrol Group Holdings plc.

There is no further information on Dan required to be disclosed under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies.

Total Voting Rights

Following Admission, there are [129,012,002] ordinary shares of £0.01 in the capital of Accrol in issue, with one voting right each. The Company does not hold any shares in treasury. The number of Ordinary Shares with voting rights is therefore [129,012,002]. Accordingly, this number should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

Enquiries:

Accrol Group Holdings plc Tel: +44 (0) 1254 278 844

Gareth Jenkins, CEO

James Flude, Finance Director

Zeus Capital Limited (Nominated Adviser & Broker)

Dan Bate / Andrew Jones Tel: +44 (0) 161 831 1512

Dominic King / John Goold Tel: +44 (0) 203 829 5000

Belvedere Communications Limited Tel: +44 (0) 203 567 0510

Cat Valentine (cvalentine@belvederepr.com) Mob: +44 (0) 7715 769 078

Kim van Beeck (kvbeeck@belvederepr.com) Mob: +44 (0) 7477 967 446

This information is provided by RNS

The company news service from the London Stock Exchange